Two vaccine doses successful in preventing 95% deaths, says ICMR study

The study was conducted on 117,524 police personnel. India has so far given 394 million vaccine doses

Police checking the vehicles during lockdown to curb the Covid19 cases at Madina Circle in Hyderabad on Thursday.
Ruchika Chitravanshi
1 min read Last Updated : Jul 16 2021 | 10:51 PM IST
A study on vaccine effectiveness in Tamil Nadu by the Indian Council of Medical Research (ICMR) has shown that two vaccine doses were successful in preventing 95 per cent of deaths due to Covid-19 in the second wave, which was driven by the Delta variant. The study was conducted on 117,524 police personnel. India has so far given 394 million vaccine doses. 


V K Paul, member (health) NITI Aayog, said the government was facilitating vaccine production in the country and the future looked optimistic. “If there is any gap in coordination (with states), we should be able to fix it. We have visibility on vaccine availability this month — around 130-140 million doses. This has been communicated to the states in advance,” he said. The study also claimed that 80 per cent of vaccinated Indians who got Covid-19 were infected by the Delta variant.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story